Vaccines pharmacovigilance dashboard
Vaccines
Consolidated Information
Updates and Resources
All diseases
20 vaccines available in the dashboard
Chikungunya
COVID-19
Dengue
Measles, Mumps and Rubella
Mpox
Respiratory Syncytial Virus
Yellow fever
Varicella
Human papillomavirus
Diphtheria, tetanus, pertussis, hepatitis B, polio and Hib
Disclaimer: This dashboard includes material compiled by PAHO from third-party sources. While PAHO has taken reasonable precautions to verify the information presented, it is distributed without a warranty of any kind. The reader is responsible for interpreting and using this information, and PAHO shall not be held liable for any damages arising from its use.
About the vaccines in this dashboard: The selection of vaccines included in this dashboard is based on various criteria, such as provision through the PAHO Revolving Fund, potential or actual use in the Region, and WHO prequalification status, with none of these being mandatory on their own.
Filter by
COVID-19
Alternative nameComirnaty (original); tozinameran; BNT162b2
Variant-adapted vaccine names
Comirnaty JN.1; Comirnaty KP.2; Comirnaty LP.8.1; Comirnaty XFG
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:BioNTech Manufacturing GmbH, Germany
Platform:RNA-based vaccine
Pharmaceutical form:Dispersion for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
-75°C (-103°F)COVID-19
Alternative nameSpikevax (original); elasomeran; mRNA-1273; TAK-919
Variant-adapted vaccine names
Spikevax JN.1; Spikevax LP.8.1; Spikevax XFG
WHO authorization status:Not prequalified
Countries authorization:
Manufacturer:Moderna TX, Inc., USA; Rovi Pharma Industrial Services S.A., Spain.
Platform:RNA-based vaccine
Pharmaceutical form:Dispersion for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
-20°C (-4°F)COVID-19
Alternative nameCoronaVac; adsorbed COVID-19 vaccine
WHO authorization status:Not prequalified
Countries authorization:
Manufacturer:Sinovac Life Sciences Ltd., China
Platform:Inactivated virus
Pharmaceutical form:Suspension for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
5°C (41°F)COVID-19
Alternative nameNuvaxovid; Covovax; NVX-CoV2373
Variant-adapted vaccine names
Nuvaxovid XBB.1.5; Nuvaxovid JN.1; Nuvaxovid XFG
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:Novavax, Czech Republic; Serum Institute of India Pvt. Ltd., India
Platform:Protein subunit
Pharmaceutical form:Dispersion for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
5°C (41°F)COVID-19
Alternative nameConvidecia; PakVac; Ad5-nCoV
WHO authorization status:Not prequalified
Countries authorization:
Manufacturer:CanSino Biologics Inc., China
Platform:Viral vector (non-replicating)
Pharmaceutical form:Suspension for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
5°C (41°F)COVID-19
Alternative nameBECOV-2
WHO authorization status:Emergency Use Listing (EUL)
Countries authorization:
Manufacturer:Biological E. Ltd., India
Platform:Recombinant protein subunit
Pharmaceutical form:Suspension for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
5°C (41°F)Chikungunya
Alternative nameVLA1553
WHO authorization status:Eligible for prequalification
Countries authorization:
Manufacturer:Valneva Ltd.
Platform:Live attenuated vaccine
Pharmaceutical form:Powder and solvent for solution for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
5°C (41°F)Chikungunya
Alternative nameChikungunya vaccine (recombinant, adsorbed); chikungunya virus-like particle vaccine, PXVX0317
WHO authorization status:Eligible for prequalification
Countries authorization:
Manufacturer:Bavarian Nordic, Denmark
Platform:Virus-like particle (VLP)
Pharmaceutical form:Suspension for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
5°C (41°F)Dengue
Alternative nameTAK-003
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:Takeda GmbH, Germany
Platform:Live attenuated vaccine
Pharmaceutical form:Powder and solvent for solution for injection
Administration route:
SubcutaneousNº of doses and schedule:
Storage:
5°C (41°F)Dengue
Alternative nameCYD-TDV
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:Sanofi Winthrop Industrie, France
Platform:Live attenuated vaccine
Pharmaceutical form:Powder and solvent for suspension for injection
Administration route:
SubcutaneousNº of doses and schedule:
Storage:
5°C (41°F)Mpox
Alternative nameImvamune; MVA-BN
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:Bavarian Nordic, Denmark
Platform:Modified vaccinia virus Ankara
Pharmaceutical form:Suspension for injection
Administration route:
SubcutaneousNº of doses and schedule:
Storage:
-20°C (-4°F)Mpox
Alternative nameLC16; LC16 KMB
WHO authorization status:Emergency Use Listing (EUL)
Countries authorization:
Manufacturer:KM Biologics Co., Japan
Platform:Live attenuated vaccine
Pharmaceutical form:Freeze-dried powder
Administration route:
PercutaneousNº of doses and schedule:
Storage:
-20°C (-4°F)Respiratory Syncytial Virus
Alternative nameBivalent RSVpreF vaccine
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:Pfizer Inc.
Platform:Recombinant protein subunit
Pharmaceutical form:Powder and solvent for solution for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
5°C (41°F)Measles, Mumps and Rubella
Alternative nameTresivac, Measles, Mumps and Rubella Vaccine, Live, Attenuated
Vaccine strain
Edmonston-Zagreb measles virus, Leningrad-Zagreb (L-Z) mumps virus and Wistar RA 27/3 rubella virus.
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:Serum Institute of India Pvt. Ltd
Platform:Live attenuated vaccine
Pharmaceutical form:Powder and solvent for suspension for injection
Administration route:
SubcutaneousNº of doses and schedule:
Storage:
5°C (41°F)Yellow fever
Alternative nameLive attenuated yellow fever vaccine, YF-VAX
Vaccine strain
Yellow fever virus strain 17D-204
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:Sanofi Winthrop Industrie, France
Platform:Live attenuated vaccine
Pharmaceutical form:Powder and solvent for suspension for injection
Administration route:
Subcutaneous or intramuscularNº of doses and schedule:
Storage:
5°C (41°F)Diphtheria, tetanus, pertussis, hepatitis B, polio and Hib
Alternative nameDTwP-HepB-Hib-IPV; Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA), Poliomyelitis (Inactivated) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed)
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:Serum Institute of India Pvt. Ltd.
Platform:Combination vaccine (toxoids, inactivated whole-cell, recombinant protein subunit, inactivated virus and polysaccharide-protein conjugate)
Pharmaceutical form:Suspension for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
5°C (41°F)Varicella
Alternative nameVaricella virus vaccine (live) [Oka/SK]; NBP608
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:SK bioscience Co., Ltd.
Platform:Live attenuated vaccine
Pharmaceutical form:Powder and solvent for suspension for injection
Administration route:
SubcutaneousNº of doses and schedule:
Storage:
5°C (41°F)Varicella
Alternative nameVaricella virus vaccine (live) [Oka/Merck]; V210
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:Merck Sharp & Dohme LLC
Platform:Live attenuated vaccine
Pharmaceutical form:Powder and solvent for suspension for injection
Administration route:
SubcutaneousNº of doses and schedule:
Storage:
5°C (41°F)Human papillomavirus
Alternative nameHuman Papillomavirus Quadrivalent Vaccine (Recombinant, adsorbed) (Types 6, 11, 16 and 18); HPV4
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:Merck Sharp & Dohme LLC
Platform:Combination vaccine (toxoids, inactivated whole-cell, recombinant protein subunit, inactivated virus and polysaccharide-protein conjugate)
Pharmaceutical form:Suspension for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
5°C (41°F)Human papillomavirus
Alternative nameHuman Papillomavirus 9-valent Vaccine (Recombinant, adsorbed) (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58); HPV9
WHO authorization status:Prequalified
Countries authorization:
Manufacturer:Merck Sharp & Dohme LLC
Platform:Virus-like particle (VLP)
Pharmaceutical form:Suspension for injection
Administration route:
IntramuscularNº of doses and schedule:
Storage:
5°C (41°F)